These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 20599873)

  • 1. High density lipoprotein-anionic peptide factor effect on reverse cholesterol transport in type 2 diabetic patients with and without coronary artery disease.
    Attia N; Lorec AM; Domingo N; Nakbi A; Hammami S; Ben Hamda K; Châaba R; Masmoudi AS; Moulin P; Portugal H; Lairon D; Chanussot F; Hammami M
    Clin Biochem; 2010 Sep; 43(13-14):1079-84. PubMed ID: 20599873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reverse modulation of the HDL anionic peptide factor and phospholipid transfer protein activity in coronary artery disease and type 2 diabetes mellitus.
    Attia N; Domingo N; Lorec AM; Nakbi A; Hammami S; Ben Hamda K; Portugal H; Lairon D; Hammami M; Chanussot F
    Clin Biochem; 2009 Jun; 42(9):845-51. PubMed ID: 19135989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of plasma cholesteryl ester transfer protein activity and polymorphism with coronary artery disease extent in Tunisian type II diabetic patients.
    Chaaba R; Hammami S; Attia N; Smaoui M; Masmoudi AS; Mahjoub S; Ben Hamda K; Hammami M
    Clin Biochem; 2005 Apr; 38(4):373-8. PubMed ID: 15766738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanism of reverse cholesterol transport: reaction of pre-beta-migrating high-density lipoprotein with plasma lecithin/cholesterol acyltransferase.
    Nakamura Y; Kotite L; Gan Y; Spencer TA; Fielding CJ; Fielding PE
    Biochemistry; 2004 Nov; 43(46):14811-20. PubMed ID: 15544352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Taq1B polymorphism of CETP gene on lipid abnormalities in patients with type II diabetes mellitus.
    Yilmaz H; Agachan B; Karaali ZE; Isbir T
    Int J Mol Med; 2004 Jun; 13(6):889-93. PubMed ID: 15138631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-density lipoproteins in the prevention of cardiovascular disease: changing the paradigm.
    Tuteja S; Rader DJ
    Clin Pharmacol Ther; 2014 Jul; 96(1):48-56. PubMed ID: 24713591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of cholesteryl ester transfer protein -629C > A polymorphism with high-density lipoprotein cholesterol levels in coronary artery disease patients.
    Tanrikulu S; Ademoglu E; Gurdol F; Mutlu-Turkoglu U; Bilge AK; Nisanci Y
    Cell Biochem Funct; 2009 Oct; 27(7):452-7. PubMed ID: 19784962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma lipoproteins from patients with poorly controlled diabetes mellitus and "in vitro" glycation of lipoproteins enhance the transfer rate of cholesteryl ester from HDL to apo-B-containing lipoproteins.
    Passarelli M; Catanozi S; Nakandakare ER; Rocha JC; Morton RE; Shimabukuro AF; Quintão EC
    Diabetologia; 1997 Sep; 40(9):1085-93. PubMed ID: 9300246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoproteins and CETP levels as risk factors for severe sepsis in hospitalized patients.
    Grion CM; Cardoso LT; Perazolo TF; Garcia AS; Barbosa DS; Morimoto HK; Matsuo T; Carrilho AJ
    Eur J Clin Invest; 2010 Apr; 40(4):330-8. PubMed ID: 20486994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The endothelial cholesterol efflux is promoted by the high-density lipoprotein anionic peptide factor.
    Domingo N; Mastellone I; Grès S; Marin V; Lorec AM; Tosini F; Grosclaude J; Farnarier C; Chanussot F
    Metabolism; 2005 Aug; 54(8):1087-94. PubMed ID: 16092060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High density- and beta-lipoprotein screening for risk of coronary artery disease in the context of new findings on reverse cholesterol transport.
    Levinson SS
    Ann Clin Lab Sci; 2002; 32(2):123-36. PubMed ID: 12017193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genetic variation of the cholesterol ester transfer protein gene and the prevalence of coronary artery disease. The AtheroGene case control study].
    Blankenberg S; Tiret L; Bickel C; Schlitt A; Jungmair W; Genth-Zotz S; Lubos E; Espinola-Klein C; Rupprecht HJ
    Z Kardiol; 2004; 93 Suppl 4():IV16-23. PubMed ID: 15085362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of lipases, lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in abnormal high density lipoprotein metabolism in insulin resistance and type 2 diabetes mellitus.
    de Vries R; Borggreve SE; Dullaart RP
    Clin Lab; 2003; 49(11-12):601-13. PubMed ID: 14651331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesteryl ester transfer protein inhibition: effect on reverse cholesterol transport?
    Rensen PC; Havekes LM
    Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):681-4. PubMed ID: 16556861
    [No Abstract]   [Full Text] [Related]  

  • 15. Modulation of plasma cholesteryl ester transfer protein activity by unsaturated fatty acids in Tunisian type 2 diabetic women.
    Smaoui M; Hammami S; Attia N; Chaaba R; Abid N; Kilani N; Kchaou H; Mahjoub S; Abid M; Hammami M
    Nutr Metab Cardiovasc Dis; 2006 Jan; 16(1):44-53. PubMed ID: 16399491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein M predicts pre-beta-HDL formation: studies in type 2 diabetic and nondiabetic subjects.
    Plomgaard P; Dullaart RP; de Vries R; Groen AK; Dahlbäck B; Nielsen LB
    J Intern Med; 2009 Sep; 266(3):258-67. PubMed ID: 19457058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atorvastatin affects low density lipoprotein and non-high density lipoprotein cholesterol relations with apolipoprotein B in type 2 diabetes mellitus: modification by triglycerides and cholesteryl ester transfer protein.
    Kappelle PJ; Zwang L; Huisman MV; Banga JD; Sluiter WJ; Dallinga-Thie GM; Dullaart RP
    Expert Opin Ther Targets; 2009 Jul; 13(7):743-51. PubMed ID: 19505224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of cholesterol in HDL and its subfractions in patients with coronary atherosclerotic heart disease.
    Jayakumari N; Raghu K; Kumari VA; Balakrishnan KG; Iyer KS
    Indian Heart J; 1993; 45(4):265-8. PubMed ID: 8138276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variations in high-density lipoprotein cholesterol in relation to physical activity and Taq 1B polymorphism of the cholesteryl ester transfer protein gene.
    Mukherjee M; Shetty KR
    Clin Genet; 2004 May; 65(5):412-8. PubMed ID: 15099350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes in the high-density lipoprotein level in patients with diabetes mellitus type II].
    Terzieva Ts; Krŭstev I; Dobrev D; Petrova V
    Vutr Boles; 1990; 29(3):89-92. PubMed ID: 2284807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.